Latest Asx News

Proteomics International’s subsidiary OxiDx has unveiled a pioneering test that detects muscle damage in thoroughbred racehorses, promising to transform recovery management in the racing industry. The test’s commercial launch is slated for the second half of 2025.

Athena Resources has partnered with Warradarge Energy and Fenix Resources to launch the Mid West Green Iron Project, aiming to produce sustainable green iron using ultra-high-grade magnetite and renewable hydrogen in Western Australia.

Asra Minerals launches a 3,000m drilling campaign at Leonora South, aiming to confirm historic gold mineralisation near its Sapphire resource. Results expected by September could reshape the project's resource potential.

Nordic Resources has expanded its gold inventory by 34%, adding 264,000 ounces from its newly updated Hirsikangas project in Finland, lifting total resources to 1.23 million ounces gold equivalent.

Tyranna Resources has agreed to acquire a 70% interest in the Maongo Copper-Gold Project in Angola, marking a strategic expansion into demand-driven metals with promising historical mining activity and strong infrastructure access.

Red Hill Minerals has reported promising new drilling results that expand gold and base metal targets at its West Pilbara project, reinforcing the potential for resource growth.

Bio-Gene Technology Limited has announced an offer of over 95 million Placement Options to investors and its Lead Manager, contingent on shareholder approval at an upcoming extraordinary general meeting. If exercised, these options could inject approximately $3.8 million into the company.

Platinum Capital Limited has unveiled a proposed restructure via a scheme of arrangement, offering shareholders the option to exchange their shares for units in the Platinum International Fund Complex ETF (PIXX). The move aims to address the persistent discount to net tangible asset value (NTA) and improve liquidity.

Platinum Asia Investments Limited (PAI) has announced a proposed restructure via a scheme of arrangement to exchange its shares for units in the Platinum Asia Fund Complex ETF (PAXX), aiming to resolve a persistent discount to net tangible asset value (NTA). The scheme, supported by independent directors and deemed fair by an expert, includes a potential special dividend and awaits shareholder and court approval.

Pharmx Technologies has resumed trading on the ASX following the renewal of its pivotal National Diabetes Services Scheme agreement, signaling stability for the healthcare tech firm.

AVJennings shareholders have overwhelmingly approved the proposed acquisition by Proprium Capital Partners and AVID, setting the stage for final court approval and a significant shift in ownership.

London City Investments reports a strong 14.8% increase in net worth for 2025, driven by gains in its investment portfolio and operating profits, outperforming the ASX All Ordinaries Index. The company also realized a significant capital gain from trimming its Fiducian Group shareholding and reinstated its Dividend Reinvestment Plan.